HIV

Early Antiretroviral Therapy May Help Prevent Progressive Brain Injury in HIV

Early Antiretroviral Therapy May Help Prevent Progressive Brain Injury in HIV

By

HIV patients had reduced brain volume and poorer cognitive performance.

Cognitive, Structural Brain Changes Occur Early After HIV Seroconversion

Cognitive, Structural Brain Changes Occur Early After HIV Seroconversion

Patients with HIV treated with cART have lower neuropsychological test scores than controls, but no significant neuropsychological decline over time.

Risk Factors for Neurocognitive Decline in HIV

Risk Factors for Neurocognitive Decline in HIV

By

Evaluating the risk factors of neurocognitive decline in HIV.

Improving Diagnosis of Mild HIV-Related Neurocognitive Disorders

Improving Diagnosis of Mild HIV-Related Neurocognitive Disorders

By

Effective cognitive screening instruments are needed in order to assess and manage milder forms of HIV-associated neurocognitive disorders.

Antiretroviral Therapy May Improve Neurodevelopmental Outcomes in HIV-Infected Infants

Antiretroviral Therapy May Improve Neurodevelopmental Outcomes in HIV-Infected Infants

By

Early detection and robust treatment are critical to limiting deficits in achieving developmental milestones in HIV-infected infants.

Antiretroviral Therapy for HIV-Associated ALS

Antiretroviral Therapy for HIV-Associated ALS

By

The results indicate HERV-K activation as a potential mechanism for HIV-associated ALS.

Early Antiretroviral Tx May Resolve Neurologic Symptoms in HIV

Early Antiretroviral Tx May Resolve Neurologic Symptoms in HIV

For the most part, symptoms tend to subside after treatment initiation.

Novel Case Suggests Alzheimer's Possible in HIV+ Patients

Novel Case Suggests Alzheimer's Possible in HIV+ Patients

Until now, it was thought that HIV-related inflammation protected the brain from amyloid deposition.

Antidepressant May Improve HIV-Associated Neurocognitive Disorder

Antidepressant May Improve HIV-Associated Neurocognitive Disorder

By

Paroxetine use improved cognitive impairment and reduced inflammation in HIV patients.

Combination HIV Antiretroviral Treatment Could Reduce Medication Frequency

Combination HIV Antiretroviral Treatment Could Reduce Medication Frequency

By

The URMC-099 compound combined with antiretroviral therapy significantly reduced HIV levels.

Antineoplastic Agents May Obscure Fungal Meningitis

Antineoplastic Agents May Obscure Fungal Meningitis

CSF cultures were negative despite worsening meningitis infection.

Ancient Viral Genes May Activate in Amyotrophic Lateral Sclerosis

Ancient Viral Genes May Activate in Amyotrophic Lateral Sclerosis

By

Researchers are now testing whether antiretroviral drugs used to treat HIV/AIDS are effective in ALS patients.

Genetics May Determine Success of HIV Vaccines

Genetics May Determine Success of HIV Vaccines

The findings may have implications for the development of future vaccines.

New HIV Antibody May Suppress Virus, Early Results Suggest

New HIV Antibody May Suppress Virus, Early Results Suggest

The new treatment would need to be combined with other HIV drugs or antibodies.

HIV Replicates, Mutates in the Brain Soon After Infection

HIV Replicates, Mutates in the Brain Soon After Infection

By

The brain can harbor active HIV even after seemingly successful antiretroviral treatment.

Coping Strategies Vary in Patients with HIV and Chronic Pain

Coping Strategies Vary in Patients with HIV and Chronic Pain

Some coping strategies like substance abuse may have negative affects on overall health.

Sign Up for Free e-newsletters

CME Focus